Psychometric Testing of the Japanese Version of the Daily Record of Severity of Problems Among Japanese Women

Takeda, Takashi; Kai, Sayaka; Yoshimi, Kana

doi:10.2147/ijwh.s301260

Cited by 5 publications

(7 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Further studies considering these factors are needed to confirm the reliability of these findings. Consecutive prospective evaluations using the Daily Record of Severity of Problem (DRSP) are recommended for accurate assessment of premenstrual symptoms [30], and it is possible to use the Japanese version of the DRSP, for which the validity and reliability have been confirmed [66]. Using DRSP assessment in a large-scale prospective study of the general public, and performing blood and stool collection at specific times during the follicular and luteal phases, respectively, would be expected to provide more definitive results.…”

Section: Plos Onementioning

confidence: 99%

Characteristics of the gut microbiota in women with premenstrual symptoms: A cross-sectional study

et al. 2022

Self Cite

View full text Add to dashboard Cite

Purpose Premenstrual symptoms can negatively impact the quality of life of women through a range of mood, behavioral, and physical symptoms. The association between the microbiota and brain function has been extensively studied. Here, we examined the characteristics of the microbiota in women with premenstrual disorders (PMDs) and the association between premenstrual symptoms and the microbiota. Materials and methods In this single center cross-sectional pilot study, we recruited 27 women reporting premenstrual symptoms and 29 women with no serious premenstrual symptoms. Among them, we further selected 21 women experiencing premenstrual symptoms resulting in interference to their social life (PMDs group) and 22 women with no serious premenstrual symptoms and thereby no interference to their social life (control group). The severity of symptoms was evaluated by a premenstrual symptoms questionnaire (PSQ). Inflammatory markers were analyzed in blood samples, including C reactive protein, soluble CD14, and lipopolysaccharide binding protein. Sequencing of 16S ribosomal ribonucleic acid genes was performed on stool samples. Results Inflammatory markers in blood samples did not differ significantly between the PMDs and control groups. A difference in beta, but not alpha diversity, was detected for the gut microbiotas of the PMDs and control groups. The relative abundance of the Bacteroidetes phylum was lower in the PMDs group. At the genus level, the prevalence was decreased for Butyricicoccus, Extibacter, Megasphaera, and Parabacteroides and increased for Anaerotaenia in the PMDs group, but after false discovery rate correction, these differences were no longer significant. Linear discriminant effect size analysis revealed a decrease in Extibacter, Butyricicoccus, Megasphaera, and Parabacteroides and an increase in Anaerotaenia in the PMDs group. The PSQ total score correlated with Anaerotaenia, Extibacter, and Parabacteroides. Multiple regression analysis showed that Parabacteroides and Megasphaera negatively predicted the PSQ total score. Conclusion The properties of the gut microbiota are associated with premenstrual symptoms.

show abstract

Section: Plos Onementioning

confidence: 99%

Characteristics of the gut microbiota in women with premenstrual symptoms: A cross-sectional study

et al. 2022

Self Cite

View full text Add to dashboard Cite

show abstract

“…[9][10][11][12] Moreover, no biomarkers have been identified for diagnosis; instead, a daily diary such as the Calendar of Premenstrual Experience 13 and the Daily Record of Severity of Problems (DRSP), 14 in which premenstrual symptoms are described, is the gold standard for accurate diagnosis. We have also translated and used the Japanese version of the DRSP (DRSP-J) in clinical trials, 15,16 but the daily description is burdensome for participants and may be difficult to use in large-scale epidemiological studies.…”

Section: Introductionmentioning

confidence: 99%

Development and Psychometric Testing of a New Short-Form of the Premenstrual Symptoms Questionnaire (PSQ-S)

Takeda

Yoshimi

Kai

et al. 2022

IJWH

Self Cite

View full text Add to dashboard Cite

Purpose The Premenstrual Symptoms Questionnaire (PSQ) is a patient-reported outcome measurement tool for premenstrual symptoms. Although the PSQ is a very useful tool with 14 items to screen for a wide variety of premenstrual symptoms, not everyone will respond to all the questions. Fewer questions would be less burdensome on the respondents. We aimed to develop and analyze the psychometric properties of a short-form of the PSQ (PSQ-S). Patients and Methods The study participants were from an earlier study with a sample of 1388 female students. We reanalyzed data collected from 922 students with regular menstrual cycles who completed the PSQ, premenstrual dysphoric disorder (PMDD) scale, Somatic Symptom Scale-8 (SSS-8), and numerical rating scale (NRS) for menstrual pain. First, we selected nine items for the PSQ-S based on the results of the corrected item-total correlation analysis. The PSQ-S was then analyzed for reliability and validity using the classical test theory. Moreover, item response theory was applied to test the psychometric properties of the PSQ-S. Results Cronbach’s α for the PSQ-S score was 0.93. Principal component factor analysis revealed a one-factor model. Confirmatory factor analysis showed that the one-factor model was a good fit. The PSQ-S total score was strongly correlated with the PSQ total score, PMDD scale score, and SSS-8 score (r=0.978, 0.854, and 0.648, respectively) and moderately correlated with the NRS (r=0.437). Item response theory analyses showed that the constructs and items of the PSQ-S had satisfactory discrimination, difficulty parameters, item information curves, and test information curves. Receiver operating characteristic curve analysis revealed a cut-off score of ≥22 for suspected premenstrual disorders based on the total PSQ-S score. Conclusion The PSQ-S, consisting of nine items from the PSQ, had sufficient reliability and validity and could be a convenient assessment tool for premenstrual symptoms in routine clinical practice.

show abstract

“…34 For Asian languages, Chinese and Japanese versions have been created and validity and reliability have been examined. [35][36][37][38][39][40] Two types of questionnaires exist in the Japanese version: the DRSP-J [36][37][38] and the J-DRSP, 39,40 which were developed independently. The Chinese version of the DRSP and DRSP-J showed strong evidence of validity and reliability as compared with the original DRSP.…”

Section: Screening and Diagnostic Questionnairesmentioning

confidence: 99%

“…The original English version has been adequately tested for reliability validity, but psychometric properties have not been fully examined 34 . For Asian languages, Chinese and Japanese versions have been created and validity and reliability have been examined 35–40 . Two types of questionnaires exist in the Japanese version: the DRSP‐J 36–38 and the J‐DRSP, 39,40 which were developed independently.…”

Section: Introductionmentioning

confidence: 99%

“…As for the J‐DRSP, it has the disadvantage that test–retest reliability is somewhat problematic, especially in the follicular phase. As to the structural validity of DRSP‐J, confirmatory factor analysis (CFA) showed that a two‐factor model (Mood and Behavior/Physical) was an acceptably good fit 38 . Conversely, J‐DRSP showed poor fit for CFA The short form of J‐DRSP was shown to be a relatively good fit, but only two evaluation methods were used 40 …”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Premenstrual disorders: Premenstrual syndrome and premenstrual dysphoric disorder

Takeda

2022

J of Obstet and Gynaecol

Self Cite

View full text Add to dashboard Cite

Recently, the term premenstrual disorders (PMDs), which includes premenstrual syndrome and premenstrual dysphoric disorder as a continuum, has been proposed. Although the precise etiology of PMDs remains unknown, the involvement of hormonal fluctuations is clear. The brain transmitters, serotonin and γ-amino butyric acid, also seem to be involved. Serotonin reuptake inhibitors and oral contraceptives are the current mainstay of treatment, but these are insufficient. Even the currently used prospective twoperiod symptom diary is not widely used in actual clinical practice, creating a major problem of discrepancy between research and clinical practice. In this review, I would like to outline the latest information and problems in the etiology, diagnosis, and treatment of PMDs, with an emphasis on promising new therapies.

show abstract

Psychometric Testing of the Japanese Version of the Daily Record of Severity of Problems Among Japanese Women

Cited by 5 publications

References 24 publications

Characteristics of the gut microbiota in women with premenstrual symptoms: A cross-sectional study

Characteristics of the gut microbiota in women with premenstrual symptoms: A cross-sectional study

Development and Psychometric Testing of a New Short-Form of the Premenstrual Symptoms Questionnaire (PSQ-S)

Premenstrual disorders: Premenstrual syndrome and premenstrual dysphoric disorder

Contact Info

Product

Resources

About